This study aimed toˆnd antibiotics or other compounds that could increase the antimicrobial activity of an antimicrobial peptide, lactoferricin B (LFcin B), against Staphylococcus aureus, including antibioticresistant strains. Among conventional antibiotics, minocycline increased the bactericidal activity of LFcin B against S. aureus, but methicillin, ceftizoxime, and sulfamethoxazole-trimethoprim did not have such an eŠect. The combination of minocycline and LFcin B had synergistic eŠects against three antibiotic-resistant strains of S. aureus, according to result of checkerboard analysis. Screening of 33 compounds, including acids and salts, alcohols, amino acids, proteins and peptides, sugar, and lipids, showed that medium-chain monoacylglycerols increased the bactericidal activity of LFcin B against three S. aureus strains. The short-term killing test in water and the killing curve test in growing cultures showed that a combination of LFcin B and monolaurin (a monoacylglycerol with a 12-carbon acyl chain) killed S. aureus more rapidly than either agent alone. Theseˆndings may be helpful in the application of antimicrobial peptides in medical or other situations.
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Key words: lactoferricin B; minocycline; monoacylglycerol; Staphylococcus aureus; bactericidal Antimicrobial peptides have been widely studied with emphasis on combating drug-resistant pathogens and some clinical trials have been done. 1, 2) To improve the application of such peptides, two strategies have been tried. One is to search for peptides or derivatives with high activity and low cost. Another is toˆnd combinations of an antimicrobial peptide with antibiotics or other compounds that have increased activity. As an example of the former approach, a potent six-residue peptide was found by screening of synthetic peptide combinatorial libraries.
3) Recently, six-and eight-residue cyclic D,L-apeptides with high e‹cacy have been found. 4) As an example of the latter approach, various antimicrobial peptides have been investigated in combination with several conventional antibiotics. [5] [6] [7] [8] Lactoferricin B (LFcin B) and lactoferricin H (LFcin H) are 25-and 47-residue cationic antimicrobial peptides generated by pepsin digestion of bovine lactoferrin (LF) and human LF, respectively. 9) LFcin B has activity against a wide range of microorganisms, including bacteria and fungi, [10] [11] [12] and the therapeutic e‹cacy of LFcin analogs has been found in several murine models of infection. [13] [14] [15] We have reported that N-acylated or D-enantiomer peptide derivatives of the nine-residue active center of LFcin B have stronger activity than LFcin B itself against bacteria and fungi. 16) In addition, LFcin B has synergistic eŠects with azole antifungal agents, even against azole-resistant Candida albicans.
17)
Toˆnd new agents for use in combination with LFcin B, we screened for substances that could improve its antimicrobial activity against Staphylococcus aureus, including antibiotic-resistant strains, testing both conventional antibiotics and various compounds. Many of the compounds that we tested were insoluble and turbid in conventional medium, making minimum inhibitory concentration (MIC) determination di‹cult. Therefore, instead of synergy analysis by MIC testing, we did mainly a killing test in a suspension. Because nutritionally rich medium or milk inhibits the antimicrobial activity of LFcin B, 16, 18) we tried toˆnd antibiotics and substances that increase the killing activity of LFcin B in MuellerHinton broth and milk, respectively.
Materials and Methods
Preparation of LFcin B, antibiotics, and other compounds. LFcin B was prepared as described previously 5) and its purity was at least 95z by HPLC. The following antibiotics were used: methicillin sodium (Banyu Pharmaceutical Co., Tokyo, Japan), ceftizoxime sodium (Fujisawa Pharmaceutical Co., Osaka, Japan), a mixture of 40z S. aureus strains. An antibiotic-susceptible S. aureus strain, JCM2151 (ATCC 6538P), was obtained from the Japan Collection of Microorganisms (RIKEN, Wako). The antibiotic-resistant S. aureus strains used were 4126, 4180, and 4229 (National Children's Hospital, Tokyo; clinical isolates) and 92005K (University of the Ryukyus, Okinawa, Japan; clinical isolate from sputum). These bacteria were resistant to methicillin (MIC, À50 mg W ml), ceftizoxime (MIC, À50 mg W ml), and sulfamethoxazole-trimethoprim (MIC, À50 mg W ml), but were moderately susceptible to minocycline (MIC, 0.3-10 mg W ml). Stock cultures were maintained in nutrient broth (Difco Laboratories, Detroit, MI) containing 10z dimethyl sulfoxide at "809 C. The cells were grown at 379 C in 1z Bactopeptone broth (Difco) for inoculation.
Killing test. S. aureus (ˆnal, 10 6 colony-forming units (CFU) W ml) in the logarithmic growth phase was suspended in pasteurized 50z-diluted cow's milk or Mueller-Hinton broth (Difco) with speciˆed concentrations of the test agents alone or in combination, and the suspensions were incubated at 379 C in duplicate. After 1 h, serial 10-fold dilutions were prepared in peptone broth and plated onto Plate Count Agar (Eiken Chemicals Co., Tokyo) for counting of CFU. Increased bactericidal activity was deˆned as a log or greater decrease in CFU caused by a combination, compared with the most active single agent. 19) The killing curve test was done in water or MuellerHinton broth with an initial cell count of about 10 5 CFU W ml in duplicate, and samples for colony counting were taken from the cultures at speciˆed times.
Checkerboard analysis. An inoculum of logarithmic-phase bacteria (10 6 CFU W ml) was cultured at 379 C for 20 h in each well of a 96-well ‰at-bottomed culture plate containing 160 ml of peptone broth with LFcin B or an antibiotic added, alone or in combination, at speciˆed concentrations. The MIC was deˆned as the lowest concentration of the agent that prevented visible growth. The minimum bactericidal concentration (MBC) was deˆned as the lowest concentration of the agent that prevented colony formation after subculture on agar medium. The lowest concentration of each drug combination causing growth inhibition or with bactericidal activity was plotted on an arithmetic scale and synergy was looked for from the shape of the curve and the fractional inhibitory concentration (FIC) index. 19 
Results

Combination of antibiotics with LFcin B
The conventional antibiotics, methicillin, ceftizoxime, sulfamethoxazole-trimethoprim, and minocycline caused only slight decreases in the viability of antibiotic-resistant S. aureus 4229 after 1 h of incubation (Table 1) . LFcin B was somewhat bactericidal at a high concentration in Mueller-Hinton broth. The eŠect of this peptide was not improved by combination with methicillin or ceftizoxime, but was somewhat improved by sulfamethoxazole-trimethoprim.
However, the bactericidal activity of LFcin B was increased by combination with minocycline; cell viability decreased more than 100-fold compared with the most active single agent. This combination also was eŠective against the antibiotic-susceptible JCM2151 strain, but not the antibiotic-resistant 92005K strain. The combination of LFcin B and minocycline was evaluated by checkerboard analysis (Fig. 1) . For this test, a nutritionally simple medium, peptone broth, was used. The plotted curves for growth inhibition of three antibiotic-resistant strains (4126, 4180, and 4229) indicated concentration-dependent synergy. The FIC indices for these strains were 0.75, 0.25, and 0.69, respectively, showing synergy (º1.0). The bactericidal activity of the combination against these strains also was synergistic. The FIC indices for killing of these strains were 0.02, 0.35, and 0.20, respectively, indicating synergy.
Screening for compounds that improve LFcin B activity
Toˆnd compounds that improved the antimicrobial activity of LFcin B, 33 compounds (acids and salts, alcohols, amino acids, proteins and peptides, sugar, acylglycerols, and other lipids) were tested for bactericidal activity against S. aureus JCM2151 during 1 h of incubation in 50z-diluted cow's milk (Table 2) . A high concentration of LFcin B at 1 mg W ml caused only a slight decrease in cell viability. Each of the compounds was tested at several concentrations, and representative results are shown in Table 2 . Cholic acid, alcohols, cysteine, lactoferrin, casein hydrolysate, casein phospho-oligopeptide, and b-cyclodextrin caused increased killing activity in combination with LFcin B. Moreover, the mediumchain monoacylglycerols MG8, MG12, and MG14 caused marked improvement in killing activity in combination with LFcin B, but other acylglycerols (including the long-chain monoacylglycerol MG18) and lipids were not eŠective.
Combination of monoacylglycerols with LFcin B
The eŠects of combinations of monoacylglycerols and LFcin B were studied further. The medium-chain monoacylglycerols MG8, MG12, and MG14 combined with LFcin B increased the bactericidal activity against strain 4229 in Mueller-Hinton broth (Table 3) . A combined eŠect was observed also with diacylglycerol DG8 toward strain 4229. The eŠects of MG12 against strains 92005K and JCM2151 were found in this assay (Table 3) . Next, a killing curve test was done with S. aureus 4229 (Fig. 2) . Figure  2 (A) shows a short-term killing test in water. MG12 (10 mg W ml) did not have any bactericidal eŠect by 10 min. LFcin B (10 mg W ml) reduced the bacteria to an undetectable level after 5 min. The combination of MG12 and LFcin B killed the bacteria more rapidly than each single agent. In growing conditions in Mueller-Hinton broth, LFcin B (100 mg W ml) did not cause any inhibition during 24 h of incubation ( Fig. 2(B) ). MG12 (100 mg W ml) killed the bacteria in a time-dependent way. The combination of MG12 and LFcin B killed bacteria even more rapidly and the cells reached undetectable numbers by 8 h.
Discussion
In this study, we investigated the eŠects of LFcin B combined with antibiotics or various compounds against S. aureus, an important mucosal pathogen. Vorland et al. reported that the combination of erythromycin and LFcin B has synergy against Escherichia coli, but synergy against S. aureus was not observed in tests of penicillin G, vancomycin, gentamicin, cycloserine, and erythromycin. 20) This study showed that minocycline synergistically improved the anti-Staphylococcus activity of LFcin B, but that methicillin, ceftizoxime, and sulfamethoxazoletrimethoprim did not. In contrast, previous treatment of S. aureus with a related antibiotic, tetracycline, decreases the killing eŠects of thrombininduced platelet microbicidal protein-1, a cationic antimicrobial peptide. 7) Taken together, these results suggest that the eŠects of minocycline on LFcin B are unusual. LF, the parent compound of LFcin, inhibits the growth of Pneumocystis carinii in combination with minocycline, but it was unclear whether the combination is synergistic. 21) The mechanism underlying the eŠects of minocycline and LFcin B has not been deˆned, but a possible hypothesis is as follows. LFcin causes membrane perturbation and thereby disrupts the proton-motive force (PMF) of microorganisms, as indicated by the in‰ow of H + 11) and the loss of membrane potential 22) in peptide-treated microbes. Loss of the PMF inhibits the function of TetA(K), which is a transporter of major facilitator superfamily energized by PMF and removes minocycline from S. aureus, 23, 24) so the cells become more susceptible to minocycline.
Gram-positive bacteria such as S. aureus are inhibited by FA esters of glycerol and, among the monoacylglycerols, MG12 is the most eŠective. 25) In fact, our results indicated that MG12 alone could kill S. aureus cells in growing conditions. When LFcin B was combined with medium-chain monoacylglycerols (MG8, MG12, and MG14, but not MG18), there was marked improvement in the anti-Staphylococcus activity. Because several antimicrobial mechanisms have been proposed for monoacylglycerols (alteration of cytoplasmic membrane, inhibition of oxidative phosphorylation, and inhibition of amino acid uptake), 26) the diŠerent antimicrobial actions of LFcin B and monoacylglycerols may explain their combined eŠect. Our previous study indicated that LFcin B derivatives with covalent N-acylation of a restricted number of carbon chains had improved Viability (z) was calculated as a percentage of CFU compared with that in the control culture after 1 h of incubation of S. aureus JCM2151 in 50z diluted cow's milk. Concentrations of each coumpound are indicated in the column and LFcin B was added at 1 mg W ml.
* A 10¿100-fold or ** aÀ100-fold decrease in viability was caused by the combination as compared with the most active single agent. 2.0 º0.016 * Viability (z) was calculated as a percentage of CFU compared with that in the control culture after 1 h of incubation in Mueller-Hinton broth. FA or acylglycerol were tested at 0.5 mg W ml and LFcin B was added at 1 mg W ml.
* A decrease of the viability by À100-fold was caused by the combination as compared with the most active single agent.
antimicrobial activity compared with LFcin B. 16) This result implies that the association of LFcin with a certain hydrophobic moiety may increase its potential for inhibiting microorganisms. A six-residue analogue of LFcin B forms a stable amphipathic structure in SDS micelles, 27) suggesting that monoacylglycerols as detergents may in‰uence the antimicrobial activity of LFcin peptides. The eŠective concentrations of LFcin B and monoacylglycerols were diŠerent in diŠerent assays. The test medium (whether milk, Mueller-Hinton broth, or water) seemed likely to in‰uence the results. It would be interesting toˆnd whether medium-chain monoacylglycerols can improve the activity of other antimicrobial peptides.
Other compounds, especially alcohols and proteins or peptides, improved the bactericidal activity of LFcin B to a lesser extent. These compounds may interact with LFcin B and in‰uence the activity of the peptide. A partial proteolysis product of bovine LF contains both bovine LF and LFcin B, and either compound may support the activity of each other.
The results of this study may provide information helpful in the clinical application of antimicrobial peptides in combination with other compounds. In particular, the combination of antimicrobial peptides with monoacylglyceorols may be useful for environmental decontamination as well as for therapeutic purposes. (A) Short-term killing was tested with LFcin B (10 mg W ml) and MG12 (10 mg W ml) alone or in combination in water. (B) The eŠects in growing conditions were tested for LFcin B (100 mg W ml) and MG12 (100 mg W ml) alone or in combination in Mueller-Hinton broth.
